Yimin Li Selected Research

N,N'- bis((2- chloroethyl)nitrosocarbamoyl)cystamine (CNCC)

11/2021	Activation of the ROS/CncC and 20-Hydroxyecdysone Signaling Pathways Is Associated with Xanthotoxin-Induced Tolerance to λ-Cyhalothrin in Spodoptera litura.
7/2021	Phytochemical Flavone Confers Broad-Spectrum Tolerance to Insecticides in Spodoptera litura by Activating ROS/CncC-Mediated Xenobiotic Detoxification Pathways.
11/2020	Adipokinetic hormone regulates cytochrome P450-mediated imidacloprid resistance in the brown planthopper, Nilaparvata lugens.
1/2020	Activation of CncC pathway by ROS burst regulates cytochrome P450 CYP6AB12 responsible for λ-cyhalothrin tolerance in Spodoptera litura.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yimin Li Research Topics

Disease

26	Neoplasms (Cancer) 08/2022 - 12/2016
20	COVID-19 01/2022 - 01/2020
16	Infections 04/2022 - 04/2011
12	Sepsis (Septicemia) 09/2021 - 09/2014
11	Critical Illness (Critically Ill) 01/2022 - 01/2015
9	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2021 - 08/2015
8	Carcinogenesis 01/2022 - 07/2015
6	Neoplasm Metastasis (Metastasis) 08/2022 - 01/2018
6	Inflammation (Inflammations) 01/2022 - 01/2014
5	Pneumonia (Pneumonitis) 01/2022 - 09/2018
4	Lung Neoplasms (Lung Cancer) 05/2022 - 08/2019
4	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 01/2018
4	Fibroma (Fibromatosis) 11/2021 - 01/2020
4	Virus Diseases (Viral Diseases) 10/2021 - 01/2020
4	Human Influenza (Influenza) 10/2021 - 01/2016
4	Lung Diseases (Lung Disease) 08/2019 - 01/2015
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2021 - 01/2019
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2021 - 01/2020
3	Fatigue 01/2021 - 07/2010
3	Ovarian Neoplasms (Ovarian Cancer) 09/2020 - 12/2016
3	Chronic Obstructive Pulmonary Disease (COPD) 08/2020 - 01/2016
3	Dyspnea (Shortness of Breath) 05/2020 - 01/2020
3	Lung Injury 01/2019 - 01/2018
3	Acute Lung Injury 01/2019 - 01/2014
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 11/2022 - 05/2022
2	Herpes Zoster 11/2022 - 08/2012
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2022 - 11/2020
2	Interstitial Lung Diseases (Interstitial Lung Disease) 02/2022 - 01/2020
2	Dermatomyositis (Dermatopolymyositis) 01/2022 - 01/2020
2	Pain (Aches) 01/2022 - 06/2020
2	Osteosarcoma (Osteogenic Sarcoma) 07/2021 - 07/2015
2	Hypoxia (Hypoxemia) 07/2021 - 01/2020
2	Acute Kidney Injury (Acute Renal Failure) 07/2021 - 03/2021
2	Glioma (Gliomas) 04/2021 - 01/2021
2	Breast Neoplasms (Breast Cancer) 04/2021 - 12/2010
2	Heart Failure 11/2020 - 01/2016
2	Obstructive Lung Diseases (Obstructive Lung Disease) 10/2020 - 01/2016
2	Postoperative Nausea and Vomiting (PONV) 06/2020 - 01/2018
2	Hemoptysis 01/2020 - 07/2018
2	Respiratory Insufficiency (Respiratory Failure) 01/2020 - 10/2018
2	Weight Loss (Weight Reduction) 01/2020 - 01/2016
2	Carcinoma (Carcinomatosis) 07/2019 - 04/2014
2	Esophageal Squamous Cell Carcinoma 07/2019 - 04/2014
2	Esophageal Neoplasms (Esophageal Cancer) 02/2019 - 01/2015

Drug/Important Bio-Agent (IBA)

11	Biomarkers (Surrogate Marker)IBA 11/2022 - 01/2015
9	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2014
6	Pharmaceutical PreparationsIBA 01/2022 - 01/2016
6	Transcription Factors (Transcription Factor)IBA 11/2021 - 07/2016
5	Protein Isoforms (Isoforms)IBA 11/2021 - 01/2018
5	CytokinesIBA 10/2021 - 08/2015
5	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2020 - 01/2018
5	MicroRNAs (MicroRNA)IBA 01/2019 - 07/2015
4	Peptides (Polypeptides)IBA 06/2022 - 01/2018
4	N,N'- bis((2- chloroethyl)nitrosocarbamoyl)cystamine (CNCC)IBA 11/2021 - 01/2020
4	Immunoglobulin G (IgG)IBA 01/2021 - 05/2016
3	VaccinesIBA 11/2022 - 08/2012
3	EnzymesIBA 01/2022 - 01/2020
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 09/2015
3	Interleukin-6 (Interleukin 6)IBA 10/2021 - 01/2019
3	AntioxidantsIBA 10/2021 - 01/2019
3	Immunoglobulin M (IgM)IBA 01/2021 - 05/2016
3	Immune Checkpoint InhibitorsIBA 01/2021 - 01/2019
3	CateninsIBA 01/2021 - 01/2019
3	Biological ProductsIBA 01/2021 - 12/2016
3	Oxygen (Dioxygen)IBA 01/2021 - 01/2020
3	Antiviral Agents (Antivirals)IBA 01/2021 - 01/2018
3	AcidsIBA 08/2019 - 05/2011
3	Ointments (Pastes)IBA 09/2015 - 08/2014
2	AutoantibodiesIBA 11/2022 - 01/2020
2	Interleukin-2 (IL2)IBA 05/2022 - 01/2022
2	Anti-Infective Agents (Microbicides)IBA 04/2022 - 01/2021
2	ProteomeIBA 01/2022 - 01/2014
2	pro-brain natriuretic peptide (1-76)IBA 09/2021 - 01/2016
2	RNA (Ribonucleic Acid)IBA 07/2021 - 11/2020
2	Sirtuin 1IBA 07/2021 - 07/2015
2	IonsIBA 04/2021 - 01/2021
2	DNA (Deoxyribonucleic Acid)IBA 04/2021 - 01/2019
2	AntibodiesIBA 01/2021 - 10/2020
2	Neutralizing AntibodiesIBA 01/2021 - 01/2015
2	Indicators and Reagents (Reagents)IBA 10/2020 - 09/2020
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2020 - 01/2020
2	Interleukin-10 (Interleukin 10)IBA 01/2019 - 01/2017
2	LipidsIBA 09/2018 - 08/2015

Therapy/Procedure

26	Therapeutics 06/2022 - 01/2014
16	Artificial Respiration (Mechanical Ventilation) 01/2022 - 08/2015
6	Drug Therapy (Chemotherapy) 05/2022 - 11/2020
6	Chemoradiotherapy 01/2020 - 04/2014
4	Extracorporeal Membrane Oxygenation 12/2022 - 01/2016
4	Mechanical Ventilators (Ventilator) 07/2021 - 08/2015
4	Length of Stay 07/2021 - 05/2016
4	Immunotherapy 04/2021 - 01/2019
4	Lung Transplantation 03/2021 - 08/2019
3	Radiotherapy 06/2022 - 02/2015
2	Renal Replacement Therapy (Therapies, Renal Replacement) 12/2022 - 07/2021
2	Intraperitoneal Injections 08/2022 - 09/2020
2	Precision Medicine 05/2022 - 01/2019
2	Ligation 03/2022 - 01/2018
2	Positive-Pressure Respiration (Positive End-Expiratory Pressure) 01/2021 - 10/2020
2	Critical Care (Surgical Intensive Care) 01/2021 - 01/2020
2	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2019 - 01/2019